drugset / Trial / NCT05269628
Mechanisms of Cannabidiol in Persons With MS: the Role of Sleep and Pain Phenotype
Phase 2
Recruiting
166 enrolled
Tiffany J. Braley, MD, MS
National Center for Complementary and Integrative Health (NCCIH) · collab
RandomizedFactorialTriple-blindSupportive care
Summary
The purpose of this research study is to compare the effects of cannabidiol (CBD), tetrahydrocannabinol (THC), or both, on sleep and pain in persons with multiple sclerosis (MS). Little is known about how CBD and/or THC may help sleep, reduce pain, or perhaps even treat pain through better sleep.
Timeline
- Start
- 2022-03-25
- Primary completion
- 2027-08-30
- Completion
- 2027-08-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cannabidiol | Other / unclassified | 100 mg | — |
| Comparator | Dronabinol | Other / unclassified | 5 mg | — |